Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.

Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P, Servais A.

Kidney Int. 2012 Jan;81(2):179-89. doi: 10.1038/ki.2011.277. Epub 2011 Sep 7.

2.

Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.

Gahl WA, Balog JZ, Kleta R.

Ann Intern Med. 2007 Aug 21;147(4):242-50.

PMID:
17709758
3.

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.

Bouazza N, Tréluyer JM, Ottolenghi C, Urien S, Deschenes G, Ricquier D, Niaudet P, Chadefaux-Vekemans B.

Orphanet J Rare Dis. 2011 Dec 23;6:86. doi: 10.1186/1750-1172-6-86.

4.

Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.

Greco M, Brugnara M, Zaffanello M, Taranta A, Pastore A, Emma F.

Pediatr Nephrol. 2010 Dec;25(12):2459-67. doi: 10.1007/s00467-010-1641-8. Epub 2010 Aug 29.

PMID:
20803298
5.

Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Langman CB, Barshop BA, Deschênes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servais A, Soliman NA, Thoene JG, Levtchenko EN; Conference Participants.

Kidney Int. 2016 Jun;89(6):1192-203. doi: 10.1016/j.kint.2016.01.033.

PMID:
27181776
6.

Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.

Bendel-Stenzel MR, Steinke J, Dohil R, Kim Y.

Pediatr Nephrol. 2008 Feb;23(2):311-5. Epub 2007 Aug 1.

PMID:
17668247
7.

Follow-up and treatment of adults with cystinosis in the Netherlands.

Geelen JM, Monnens LA, Levtchenko EN.

Nephrol Dial Transplant. 2002 Oct;17(10):1766-70.

PMID:
12270982
8.

Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.

Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA.

Medicine (Baltimore). 2005 May;84(3):137-46.

9.

NIH conference. Cystinosis: progress in a prototypic disease.

Gahl WA, Thoene JG, Schneider JA, O'Regan S, Kaiser-Kupfer MI, Kuwabara T.

Ann Intern Med. 1988 Oct 1;109(7):557-69. Review.

PMID:
3048161
10.

Pharmacological treatment of nephropathic cystinosis with cysteamine.

Kleta R, Gahl WA.

Expert Opin Pharmacother. 2004 Nov;5(11):2255-62. Review.

PMID:
15500372
11.

Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine.

Dureau P, Broyer M, Dufier JL.

J Pediatr Ophthalmol Strabismus. 2003 May-Jun;40(3):142-6.

PMID:
12795432
12.

Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Nesterova G, Williams C, Bernardini I, Gahl WA.

Pediatr Nephrol. 2015 Jun;30(6):945-51. doi: 10.1007/s00467-014-3018-x. Epub 2014 Dec 20.

PMID:
25526929
13.

[Cystinosis in adults: A systemic disease].

Servais A, Goizet C, Bertholet-Thomas A, Decramer S, Llanas B, Choukroun G, Novo R.

Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Epub 2015 Mar 11. Review. French.

PMID:
25769364
14.

Nephropathic cystinosis: late complications of a multisystemic disease.

Nesterova G, Gahl W.

Pediatr Nephrol. 2008 Jun;23(6):863-78. Review.

PMID:
18008091
15.

Follow-up and treatment of renal transplantation with nephropathic cystinosis in central Taiwan.

Chuang YW, Wen MC, Wu MJ, Shu KH, Cheng CH, Yu TM, Huang ST, Chen CH.

Transplant Proc. 2012 Jan;44(1):80-2. doi: 10.1016/j.transproceed.2011.12.071.

PMID:
22310585
16.

Nephropathic cystinosis in children: An overlooked disease.

Soliman NA, El-Baroudy R, Rizk A, Bazaraa H, Younan A.

Saudi J Kidney Dis Transpl. 2009 May;20(3):436-42.

17.

Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.

Ahlenstiel-Grunow T, Kanzelmeyer NK, Froede K, Kreuzer M, Drube J, Lerch C, Pape L.

Pediatr Nephrol. 2017 Jan;32(1):91-97. Epub 2016 Jun 27.

PMID:
27350621
18.

Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.

Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA.

J Clin Endocrinol Metab. 1995 Nov;80(11):3257-61.

PMID:
7593434
19.

Long-term treatment of infantile nephropathic cystinosis with cysteamine.

da Silva VA, Zurbrügg RP, Lavanchy P, Blumberg A, Suter H, Wyss SR, Lüthy CM, Oetliker OH.

N Engl J Med. 1985 Dec 5;313(23):1460-3. No abstract available.

PMID:
4058549
20.

Parenchymal organ cystine depletion with long-term cysteamine therapy.

Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC.

Biochem Med Metab Biol. 1992 Dec;48(3):275-85.

PMID:
1476793

Supplemental Content

Support Center